Adverse events in patients with cardiovascular disease taking proton pump inhibitors.

Introduction: Proton pump inhibitors (PPIs) rank among the most frequently prescribed medications to treat acid-related diseases. Mounting concerns surround the potential for serious adverse events, including cardiovascular events, associated with their prolonged use/misuse.

Areas Covered: This comprehensive review explores cardiovascular adverse events linked to PPI use among high-risk cardiovascular patients.

[Quality of life and its association with the severity of fecal incontinence].

Background: Wexner's score is widely used to assess the severity of fecal incontinence (FI). The 36-item short form health survey (SF-36) and the Fecal Incontinence Quality of Life Scale (FIQLS), a disease-specific scale, are instruments measuring quality of life that have been validated into Spanish.

Aim: To evaluate quality of life in patients with FI by using the FIQL and SF-36 scales to correlate the results with the Wexner's score.